WO2001018044A3 - Modulation par semaphorines de l'efflux cellulaire - Google Patents
Modulation par semaphorines de l'efflux cellulaire Download PDFInfo
- Publication number
- WO2001018044A3 WO2001018044A3 PCT/US2000/024560 US0024560W WO0118044A3 WO 2001018044 A3 WO2001018044 A3 WO 2001018044A3 US 0024560 W US0024560 W US 0024560W WO 0118044 A3 WO0118044 A3 WO 0118044A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulation
- semaphorin
- cellular efflux
- semaphorins
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00961634A EP1210368A2 (fr) | 1999-09-08 | 2000-09-07 | Modulation par semaphorines de l'efflux cellulaire |
AU73556/00A AU770157B2 (en) | 1999-09-08 | 2000-09-07 | Use of semaphorin for modulation of cellular efflux |
CA002384104A CA2384104A1 (fr) | 1999-09-08 | 2000-09-07 | Modulation par semaphorines de l'efflux cellulaire |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15291499P | 1999-09-08 | 1999-09-08 | |
US60/152,914 | 1999-09-08 | ||
US15625799P | 1999-09-27 | 1999-09-27 | |
US60/156,257 | 1999-09-27 | ||
US17390699P | 1999-12-29 | 1999-12-29 | |
US60/173,906 | 1999-12-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001018044A2 WO2001018044A2 (fr) | 2001-03-15 |
WO2001018044A3 true WO2001018044A3 (fr) | 2001-10-25 |
Family
ID=27387351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/024560 WO2001018044A2 (fr) | 1999-09-08 | 2000-09-07 | Modulation par semaphorines de l'efflux cellulaire |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1210368A2 (fr) |
AU (1) | AU770157B2 (fr) |
CA (1) | CA2384104A1 (fr) |
WO (1) | WO2001018044A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002010217A2 (fr) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Profils d'expression de cellules endotheliales |
EP1429801A1 (fr) * | 2001-09-26 | 2004-06-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neuropiline comme nouvelle cible therapeutique pour la modulation de reponses immunitaires |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007706A1 (fr) * | 1993-09-13 | 1995-03-23 | The Regents Of The University Of California | Famille du gene de la semaphorine |
WO1999021997A1 (fr) * | 1997-10-28 | 1999-05-06 | Immunex Corporation | Adn et polypeptides recepteurs des proteines de semaphorine a codage viral |
WO1999045114A2 (fr) * | 1998-03-03 | 1999-09-10 | Zymogenetics, Inc. | Semaphorine humaine zsmf-7 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270831B (it) * | 1993-09-17 | 1997-05-13 | Romano Deghenghi | Composizioni farmaceutiche orali effervescenti contenenti estrone |
-
2000
- 2000-09-07 WO PCT/US2000/024560 patent/WO2001018044A2/fr not_active Application Discontinuation
- 2000-09-07 EP EP00961634A patent/EP1210368A2/fr not_active Withdrawn
- 2000-09-07 CA CA002384104A patent/CA2384104A1/fr not_active Abandoned
- 2000-09-07 AU AU73556/00A patent/AU770157B2/en not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007706A1 (fr) * | 1993-09-13 | 1995-03-23 | The Regents Of The University Of California | Famille du gene de la semaphorine |
US5935865A (en) * | 1993-09-13 | 1999-08-10 | The Regents Of The University Of California | Semaphorin gene family |
WO1999021997A1 (fr) * | 1997-10-28 | 1999-05-06 | Immunex Corporation | Adn et polypeptides recepteurs des proteines de semaphorine a codage viral |
WO1999045114A2 (fr) * | 1998-03-03 | 1999-09-10 | Zymogenetics, Inc. | Semaphorine humaine zsmf-7 |
Non-Patent Citations (4)
Title |
---|
ALTAN ET AL: "Defective acidification in human breast tumor cells and implications for chemotherapy", JOURNAL OF EXPERIMENTAL MEDICINE,JP,TOKYO, vol. 187, no. 10, 18 May 1998 (1998-05-18), pages 1583 - 1598, XP002118974, ISSN: 0022-1007 * |
J. H. WEISBURG ET AL: "Intracellular pH and Multidrug Resistance Regulate Complement-mediated Cytotoxicity of Nucleated Human Cells", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 16, 16 April 1999 (1999-04-16), pages 10877 - 10888, XP002164647 * |
M SCHINDLER ET AL: "Defective pH Regulation of Acidic Compartments in Human Breast Cancer Cells (MCF-7) Is Normalized in Adriamycin-Resistant Cells (MCF-7adr)", BIOCHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. EASTON, PA, vol. 35, no. 9, 5 March 1996 (1996-03-05), pages 2811 - 2817, XP002118976, ISSN: 0006-2960 * |
TESSHI YAMADA ET AL: "Identification of semaphorin E as a non-MDR drug resistance gene of human cancers", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 94, December 1997 (1997-12-01), pages 14713 - 14718, XP002164646 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001018044A2 (fr) | 2001-03-15 |
CA2384104A1 (fr) | 2001-03-15 |
AU770157B2 (en) | 2004-02-12 |
AU7355600A (en) | 2001-04-10 |
EP1210368A2 (fr) | 2002-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999011791A3 (fr) | Recepteurs et ligands de la famille du facteur de necrose tumorale, acides nucleiques codants et agents de liaison associes | |
ZA200309460B (en) | Novel Benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl trasferase proteins. | |
AU4498500A (en) | Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof | |
DE69922986D1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
WO2002099084A3 (fr) | Polypeptides de liaison composites | |
AU2002357634A1 (en) | Improvements in, or relating to, mobile localization in gsm networks | |
ZA200007638B (en) | Pyrazoline derivatives, their preparation and application as medicaments. | |
DE60001451T2 (de) | 1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung | |
AU2001246671A1 (en) | Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands | |
WO2002041854A3 (fr) | Composition cosmetique anhydre resistant au transfert | |
ATE231869T1 (de) | Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung | |
ZA200300744B (en) | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same. | |
DE60103054D1 (de) | Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung | |
ZA200206808B (en) | Endoparasiticidal gel composition. | |
AU2002228805A1 (en) | Antisense modulation of damage-specific dna binding protein 2, p48 expression | |
AU2003303974A1 (en) | Organic-inorganic hybrid composite, preparation thereof and anti-fogging coating composition comprising same | |
DE69808664D1 (de) | Feuerfeste metall-silizid-legierung sputter-targets, dessen verwendung und herstellung | |
WO2001018044A3 (fr) | Modulation par semaphorines de l'efflux cellulaire | |
AU2469499A (en) | Tissue resection using resistance heating | |
DE60144456D1 (de) | DibenzoÄb,fÜazepin-Derivate und ihre Herstellung | |
PL372297A1 (en) | 5-membered heterocycles, preparation and application thereof as medicaments | |
AU4779400A (en) | Hair-treatment composition | |
AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
AU6846500A (en) | Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof | |
AU2002335977A1 (en) | Protein biopolymer markers predictive of insulin resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2384104 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 517699 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000961634 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 73556/00 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000961634 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 517699 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 517699 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 73556/00 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000961634 Country of ref document: EP |